Kodlipet Dharmashankar

1.7k total citations
26 papers, 1.3k citations indexed

About

Kodlipet Dharmashankar is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, Kodlipet Dharmashankar has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pharmacology and 5 papers in Surgery. Recurrent topics in Kodlipet Dharmashankar's work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Cardiovascular Health and Disease Prevention (7 papers) and Blood Pressure and Hypertension Studies (5 papers). Kodlipet Dharmashankar is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Cardiovascular Health and Disease Prevention (7 papers) and Blood Pressure and Hypertension Studies (5 papers). Kodlipet Dharmashankar collaborates with scholars based in United States, Japan and Spain. Kodlipet Dharmashankar's co-authors include Michael E. Widlansky, Dominick J. Angiolillo, Davide Capodanno, Jingli Wang, David D. Gutterman, Rong Ying, Tinoy Kizhakekuttu, José Luis Ferreiro, Masafumi Ueno and Bhaloo Desai and has published in prestigious journals such as Journal of the American College of Cardiology, Hypertension and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Kodlipet Dharmashankar

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kodlipet Dharmashankar United States 17 807 307 244 204 180 26 1.3k
Neil P. Andrews United States 16 837 1.0× 237 0.8× 490 2.0× 92 0.5× 126 0.7× 21 1.4k
Recep Demirbağ Türkiye 24 590 0.7× 231 0.8× 143 0.6× 149 0.7× 220 1.2× 120 1.6k
Enrico Arosio Italy 17 399 0.5× 292 1.0× 147 0.6× 155 0.8× 162 0.9× 72 1.2k
Natale Vazzana Italy 19 549 0.7× 218 0.7× 160 0.7× 346 1.7× 218 1.2× 31 1.5k
Mukesh Singh United States 21 492 0.6× 288 0.9× 278 1.1× 117 0.6× 93 0.5× 63 1.2k
Arthur Schwartzbard United States 20 684 0.8× 407 1.3× 194 0.8× 424 2.1× 217 1.2× 53 1.4k
Th. Thien Netherlands 17 392 0.5× 273 0.9× 147 0.6× 167 0.8× 133 0.7× 57 1.0k
Ján Murín Slovakia 15 782 1.0× 252 0.8× 152 0.6× 173 0.8× 99 0.6× 84 1.2k
Nobutaka Hirai Japan 17 895 1.1× 227 0.7× 310 1.3× 411 2.0× 186 1.0× 28 1.6k
И Е Чазова Russia 21 1.4k 1.8× 224 0.7× 194 0.8× 195 1.0× 92 0.5× 331 2.1k

Countries citing papers authored by Kodlipet Dharmashankar

Since Specialization
Citations

This map shows the geographic impact of Kodlipet Dharmashankar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kodlipet Dharmashankar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kodlipet Dharmashankar more than expected).

Fields of papers citing papers by Kodlipet Dharmashankar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kodlipet Dharmashankar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kodlipet Dharmashankar. The network helps show where Kodlipet Dharmashankar may publish in the future.

Co-authorship network of co-authors of Kodlipet Dharmashankar

This figure shows the co-authorship network connecting the top 25 collaborators of Kodlipet Dharmashankar. A scholar is included among the top collaborators of Kodlipet Dharmashankar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kodlipet Dharmashankar. Kodlipet Dharmashankar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jingli, Rong Ying, Sergey Tarima, et al.. (2015). Mineralocorticoid exposure and receptor activity modulate microvascular endothelial function in African Americans with and without hypertension. Vascular Medicine. 20(5). 401–408. 11 indexed citations
2.
Durand, Matthew J., et al.. (2014). Acute Exertion Elicits a H 2 O 2 -Dependent Vasodilator Mechanism in the Microvasculature of Exercise-Trained but Not Sedentary Adults. Hypertension. 65(1). 140–145. 52 indexed citations
3.
Strath, Scott J., et al.. (2014). The impact of moderate intensity physical activity on cardiac structure and performance in older sedentary adults. PubMed. 4. 19–24. 9 indexed citations
4.
Suboc, Tisha, Kodlipet Dharmashankar, Jingli Wang, et al.. (2013). Moderate obesity and endothelial dysfunction in humans: influence of gender and systemic inflammation. Physiological Reports. 1(3). 37 indexed citations
5.
Ueno, Masafumi, José Luis Ferreiro, Bhaloo Desai, et al.. (2012). Cigarette Smoking Is Associated With a Dose-Response Effect in Clopidogrel-Treated Patients With Diabetes Mellitus and Coronary Artery Disease. JACC: Cardiovascular Interventions. 5(3). 293–300. 40 indexed citations
6.
Dharmashankar, Kodlipet, Jingli Wang, Tinoy Kizhakekuttu, et al.. (2012). Nitric Oxide Synthase-Dependent Vasodilation of Human Subcutaneous Arterioles Correlates With Noninvasive Measurements of Endothelial Function. American Journal of Hypertension. 25(5). 528–534. 34 indexed citations
7.
Ferreiro, José Luis, Masafumi Ueno, Antonio Tello‐Montoliu, et al.. (2012). Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation. Journal of Thrombosis and Thrombolysis. 35(2). 155–164. 22 indexed citations
8.
Capranzano, Piera, José Luis Ferreiro, Masafumi Ueno, et al.. (2012). Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on‐treatment platelet reactivity and diabetes mellitus status. Catheterization and Cardiovascular Interventions. 81(1). 42–49. 15 indexed citations
9.
Ueno, Masafumi, José Luis Ferreiro, Kodlipet Dharmashankar, et al.. (2011). SERUM COTININE LEVELS ARE ASSOCIATED WITH INCREASED CLOPIDOGREL-INDUCED ANTIPLATELET EFFECTS IN PATIENTS WITH DIABETES MELLITUS AND CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 57(14). E1919–E1919. 1 indexed citations
10.
Wang, Jingli, Rong Ying, Tinoy Kizhakekuttu, et al.. (2011). Acute Exposure to Low Glucose Rapidly Induces Endothelial Dysfunction and Mitochondrial Oxidative Stress. Arteriosclerosis Thrombosis and Vascular Biology. 32(3). 712–720. 110 indexed citations
11.
Ueno, Masafumi, José Luis Ferreiro, Salvatore D. Tomasello, et al.. (2011). Impact of Pentoxifylline on Platelet Function Profiles in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel. JACC: Cardiovascular Interventions. 4(8). 905–912. 15 indexed citations
12.
Angiolillo, Dominick J., Piera Capranzano, José Luis Ferreiro, et al.. (2011). Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. Thrombosis and Haemostasis. 106(8). 253–262. 32 indexed citations
13.
Capodanno, Davide, Kodlipet Dharmashankar, José Luis Ferreiro, et al.. (2011). PHARMACODYNAMIC EFFECTS OF DIFFERENT ASPIRIN DOSING REGIMENS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 57(14). E1910–E1910. 12 indexed citations
14.
Dharmashankar, Kodlipet & Michael E. Widlansky. (2010). Vascular Endothelial Function and Hypertension: Insights and Directions. Current Hypertension Reports. 12(6). 448–455. 348 indexed citations
15.
Rezkalla, Shereif H., et al.. (2010). No‐Reflow Phenomenon Following Percutaneous Coronary Intervention for Acute Myocardial Infarction: Incidence, Outcome, and Effect of Pharmacologic Therapy. Journal of Interventional Cardiology. 23(5). 429–436. 108 indexed citations
16.
Ferreiro, José Luis, Masafumi Ueno, Davide Capodanno, et al.. (2010). Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake. Circulation Cardiovascular Interventions. 3(5). 436–441. 48 indexed citations
17.
Ueno, Masafumi, José Luis Ferreiro, Kodlipet Dharmashankar, et al.. (2010). CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY. Journal of the American College of Cardiology. 55(10). A206.E1946–A206.E1946. 1 indexed citations
18.
Capodanno, Davide, Kodlipet Dharmashankar, & Dominick J. Angiolillo. (2010). Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12receptor antagonist. Expert Review of Cardiovascular Therapy. 8(2). 151–158. 70 indexed citations
19.
Dharmashankar, Kodlipet, Juan F. Granada, P.-H. Chyou, et al.. (2009). Atrial Flutter Versus Atrial Fibrillation in a General Population: Differences in Comorbidities Associated With Their Respective Onset. Clinical Medicine & Research. 8(1). 1–6. 20 indexed citations
20.
Dharmashankar, Kodlipet, et al.. (2004). Role of Magnetic Resonance Imaging in Visualizing Coronary Arteries. Clinical Medicine & Research. 2(3). 173–179. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026